My Portfolio

Abbott Laboratories ABT:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 06/03/26 EDT

86.75

-0.24 (-0.28%)

Volume

418,861

86.99

+0.02 (+0.02%)

Volume

9,975,794

52 week range

81.97 - 139.06

Open87.20
Day High88.11
Day Low86.72
Prev Close86.97
52 Week High139.06
52 Week High Date06/24/25
52 Week Low81.97
52 Week Low Date05/11/26

Latest On Abbott Laboratories

The demand for healthcare is going to continue to accelerate, says Abbott Labs CEO Robert FordJune 2, 2026CNBC.com
Cramer’s Stop Trading: Boston ScientificMay 27, 2026CNBC.com
Dividend growth stocks for down markets, per Trivariate ResearchMay 19, 2026CNBC.com
Too far, too fast? Some stocks are very stretched compared to historyMay 15, 2026CNBC.com
Cramer’s Stop Trading: Charles SchwabMay 15, 2026CNBC.com
Jim Cramer on the current market: Hated companies are over-hated, and the loved ones are over-lovedMay 11, 2026CNBC.com
Jim Cramer says today’s market is punishing stocks harder than 1999May 11, 2026CNBC.com
Cramer: It's not too late to start buying red-hot AI stocks. Here's why May 10, 2026CNBC.com
Lightning Round: 'Rocket Lab is a winner', says Jim CramerApril 27, 2026CNBC.com
Jim Cramer's top 10 things to watch in the stock market FridayApril 17, 2026CNBC.com

Key Stats

Market Cap151.52B
Shares Out1.74B
10 Day Average Volume11.08M
Dividend2.52
Dividend Yield2.90%
Beta0.62

Latest On Abbott Laboratories

The demand for healthcare is going to continue to accelerate, says Abbott Labs CEO Robert FordJune 2, 2026CNBC.com
Cramer’s Stop Trading: Boston ScientificMay 27, 2026CNBC.com
Dividend growth stocks for down markets, per Trivariate ResearchMay 19, 2026CNBC.com
Too far, too fast? Some stocks are very stretched compared to historyMay 15, 2026CNBC.com
Cramer’s Stop Trading: Charles SchwabMay 15, 2026CNBC.com
Jim Cramer on the current market: Hated companies are over-hated, and the loved ones are over-lovedMay 11, 2026CNBC.com
Jim Cramer says today’s market is punishing stocks harder than 1999May 11, 2026CNBC.com
Cramer: It's not too late to start buying red-hot AI stocks. Here's why May 10, 2026CNBC.com
Lightning Round: 'Rocket Lab is a winner', says Jim CramerApril 27, 2026CNBC.com
Jim Cramer's top 10 things to watch in the stock market FridayApril 17, 2026CNBC.com

KEY STATS

Open87.20
Day High88.11
Day Low86.72
Prev Close86.97
52 Week High139.06
52 Week High Date06/24/25
52 Week Low81.97
52 Week Low Date05/11/26
Market Cap151.52B
Shares Out1.74B
10 Day Average Volume11.08M
Dividend2.52
Dividend Yield2.90%
Beta0.62

RATIOS/PROFITABILITY

EPS (TTM)3.59
P/E (TTM)24.23
Fwd P/E (NTM)15.52
EBITDA (TTM)11.289B
ROE (TTM)12.44%
Revenue (TTM)45.134B
Gross Margin (TTM)56.47%
Net Margin (TTM)13.91%
Debt To Equity (MRQ)65.40%

EVENTS

Earnings Date07/15/2026(est)
Ex Div Date04/15/2026
Div Amount0.63
Split Date-
Split Factor-

Content From Our Affiliates

MiniMed announces expanded ketone sensor agreement with Abbott16 Hours AgoTipRanks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nuvalent (NUVL), Abbott Laboratories (ABT) and Abivax SA Sponsored ADR (ABVX)June 2, 2026TipRanks
SCHD Is Down 20% This Year. Do Analysts See a Rebound Ahead?June 1, 2026TipRanks
Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/29/2026May 29, 2026TipRanks
Analysts Are Bullish on These Healthcare Stocks: Abbott Laboratories (ABT), Inventiva (IVA)May 29, 2026TipRanks

Profile

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products...

Robert Ford

Chairman of the Board and Chief Executive Officer

Philip Boudreau

Executive Vice President - Finance and Chief Financial Officer

Louis Morrone

Executive Vice President - Core Diagnostics

Daniel Salvadori

Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products

Christopher Scoggins

Executive Vice President - Diabetes Care

John McCoy Jr.

Vice President - Finance and Controller

Address

100 Abbott Park Road, Abbot Park

Abbott Park, IL

60064-3500

United States

https://www.abbott.com